Portal:AOP/FeaturedPathways

Revision as of 11:21, 27 March 2018 by Marvin M2 (Talk | contribs)

Pathway:WP3997 : Epilepsy Adverse Outcome Pathway (Homo sapiens)
Pathway:WP3980 : Protein alkylation leading to liver fibrosis (Homo sapiens)
Pathway:WP3624 : Lung fibrosis (Homo sapiens)
Pathway:WP3632 : Lung fibrosis (Mus musculus)
Pathway:WP4010 : Liver steatosis AOP (Homo sapiens)
Pathway:WP4011 : Steatosis AOP (Homo sapiens)
Pathway:WP4017 : Selective serotonin reuptake inhibitors lead to several adverse outcomes (Homo sapiens)
Pathway:WP4026 : Gastric ulcer formation (Homo sapiens)
Pathway:WP2643 : Nanoparticle-mediated activation of receptor signaling (Homo sapiens)
Pathway:WP2507 : Nanomaterial induced apoptosis (Homo sapiens)
Pathway:WP2513 : Nanoparticle triggered regulated necrosis (Homo sapiens)
Pathway:WP2509 : Nanoparticle triggered autophagic cell death (Homo sapiens)
Pathway:WP3287 : Overview of nanoparticle effects (Homo sapiens)
Pathway:WP3890 : Nanomaterial induced inflammasome activation (Homo sapiens)
Pathway:WP3181 : Nanoparticle-mediated activation of receptor signaling (Bos taurus)